Skip to content
OpenCapital
Get started

Polaryx Therapeutics, Inc. PLYX Balance Sheet Statement

Income StatementBalance SheetCash FlowRatiosSegments
QuarterlyAnnualTTM
YoYQoQ
SimplifiedDetailed
TTM Q1 '25
Cash and cash equivalents
——
Total current assets
——
Total assets
——
Accounts payable
-$145.5K+36.4%
Total current liabilities
——
Total liabilities
——
Common stock
——
Retained earnings
——
Total stockholders' equity
——
Total liabilities and stockholders' equity
——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Polaryx Therapeutics, Inc. 's total assets?
Polaryx Therapeutics, Inc. (PLYX) holds $3.5M in total assets.
How much cash does Polaryx Therapeutics, Inc. have?
Polaryx Therapeutics, Inc. holds $3.1M in cash and equivalents.
Can Polaryx Therapeutics, Inc. cover its short-term obligations?
Its current ratio is 3.45 — current assets exceed current liabilities.
Where does Polaryx Therapeutics, Inc. 's balance sheet data come from?
Every line is extracted from Polaryx Therapeutics, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.